Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Hydatid disease Clinical Microbiology and Infection
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland  C. Pulcini, F. Williams, N. Molinari,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Elements of design: the knowledge on which we build
André Bryskier  Clinical Microbiology and Infection 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
W.A. Craig  Clinical Microbiology and Infection 
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Training in infectious diseases and tropical medicine in Britain
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
Sanford Chodosh  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical Microbiology and Infection  Volume 4, Issue 9, Pages 537-551 (September 1998) DOI: 10.1111/j.1469-0691.1998.tb00413.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Current UK models for delivering OHPAT antibiotics. IV. intravenous. Clinical Microbiology and Infection 1998 4, 537-551DOI: (10.1111/j.1469-0691.1998.tb00413.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Estimated number of the UK population receiving OHPAT. Clinical Microbiology and Infection 1998 4, 537-551DOI: (10.1111/j.1469-0691.1998.tb00413.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.